Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-05Clinical Trial Update: CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
A completed clinical study evaluated the kinetics of CNS and plasma amyloid-beta in people with Alzheimer's disease. The update reports biom…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Treatment for Aggression and Agitation in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating a treatment for aggression and agitation in Alzheimer's disease by Eli Lilly has completed, with results p…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease [NA]
A clinical trial evaluating rosiglitazone extended-release tablets as an adjunctive therapy for mild-to-moderate Alzheimer's disease has com…
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial evaluating the safety and effects of autologous adipose-derived stromal cells in Alzheimer's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia [Phase 1, Phase 2]
The document reports that Phase 1 and Phase 2 studies of ITI-007 (lumateperone) in healthy elderly volunteers and elderly patients with Alzh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Retinal Neurodegenerative Signs in Alzheimer's Diseases [NA]
This document provides an update on a completed clinical trial evaluating retinal neurodegenerative signs in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers [Phase 3]
This entry notes the termination and posting of results for an open-label extension study of Rosiglitazone XR as adjunctive therapy in mild-…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Cataract Removal and Alzheimer's Disease [NA]
A completed clinical trial investigating cataract removal in relation to Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers [Phase 3]
A Phase 3 study of Rosiglitazone XR in subjects with mild-to-moderate Alzheimer's disease was terminated, and results were posted in 2017.
-
CLINICAL_TRIALS research · 2017-11-07Clinical Trial Update: Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
This clinical trial update describes a study using chromatic pupillometry to assess the melanopsin-light pathway in Progressive Supranuclear…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers [Phase 2]
A Phase 2 trial evaluating cognitive-behavioral therapy for patients with mild Alzheimer's disease and their caregivers has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Central and Systemic Inflammation in Alzheimer's Disease
The clinical trial examining central and systemic inflammation in Alzheimer's disease has completed. No results are provided in the snippet.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Evaluation of [18F]RO6958948 as Tracer for Positron Emission Tomography (PET) Imaging of Tau Burden in Alzheimer's Disease Participants [Phase 1]
This Phase 1 clinical trial evaluates the PET tracer [18F]RO6958948 for imaging tau burden in Alzheimer's disease. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: Imaging of Cognition, Learning, and Memory in Aging
This update reports the completion of a clinical trial examining imaging measures of cognition, learning, and memory in aging, in the contex…
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis [Phase 2]
Phase 2 study results for pimavanserin in Alzheimer's disease psychosis have been posted from a completed trial.
-
CLINICAL_TRIALS trial_result · 2017-10-18Clinical Trial Update: Therapeutic Role of Transcranial DCS in Alzheimer [NA]
A completed clinical trial evaluated the therapeutic role of transcranial direct current stimulation in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-10-16Clinical Trial Update: Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial of aripiprazole for agitation in Alzheimer's disease-associated dementia was terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Phase 3]
This update summarizes Phase 3 trial results for the rivastigmine transdermal patch in probable Alzheimer's disease. It highlights efficacy …
-
CLINICAL_TRIALS research · 2017-10-13Clinical Trial Update: tDCS Effect on Cognitive Functions From Patients With Alzheimer's Disease or Progressive Primary Aphasia [NA]
This entry reports an ongoing clinical trial evaluating whether transcranial direct current stimulation (tDCS) can improve cognitive functio…
-
CLINICAL_TRIALS research · 2017-10-12Clinical Trial Update: Self-Directed Online Training for Chinese Caregivers [NA]
This document serves as a clinical trial update for a self-directed online training program for Chinese caregivers of people with dementia a…
-
CLINICAL_TRIALS trial_result · 2017-10-10Clinical Trial Update: The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study [NA]
The PLasma for Alzheimer's Symptom Amelioration (PLASMA) study investigating plasma-based therapy for Alzheimer's disease has completed.
-
FDA approval · 2017-09-28FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Torrent Pharmaceuticals Limited to market donepezil hydrochloride as a generic product for the t…
-
FDA approval · 2017-09-28FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Chartwell RX, LLC)
FDA approves the original application for rivastigmine tartrate (generic) manufactured by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2017-09-21Clinical Trial Update: Effect of Insulin Sensitizer Metformin on AD Biomarkers [Phase 2]
Phase 2 trial assessing metformin, an insulin sensitizer, on Alzheimer's disease biomarkers; completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil [Phase 3]
Phase 3 trial investigating idalopirdine added to donepezil in mild-to-moderate Alzheimer's disease has completed with results posted in 201…